Failure to pay annual charges - regulatory actions

If a sponsor has failed to pay the annual charge for therapeutic goods within 28 days (20 working days for medical devices) after it becomes payable, the Secretary can cancel the entry of therapeutic goods in the Australian Register of Therapeutic Goods (ARTG).

The cancellation provisions relating to failure to pay annual charges in the Therapeutic Goods Act 1989 are:

  • cancellation of listed or registered therapeutic goods: section 30(2)(f)
  • cancellation of biologicals: section 32GA(1)(g)
  • cancellation of medical devices: section 41GL(f).

The records below include information on the cancellation decisions and any subsequent decision to revoke such cancellations. To find out whether a product is currently authorised for supply in Australia, check the ARTG.

Enter a product name or an ARTG number.

Cancellations

Displaying 61 - 70 of 2259

BioHealth Pty Ltd

Product: ProVent

ARTG number: 196204

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

High Desert Co Pty Ltd

Product: Omega-3 1000mg Salmon oil + Vitamin E

ARTG number: 162531

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: Magnesium Complex 300 mg

ARTG number: 226425

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: Propolis 500mg Gelatin 00 Hard Capsule

ARTG number: 223292

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: Chlorella 500 mg

ARTG number: 210409

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: Chlorella 1000mg

ARTG number: 210266

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: VitaCaps D3 1000

ARTG number: 196935

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: OmegCap Neptune Krill Oil 1000 mg

ARTG number: 196605

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: OmegCap Neptune Krill Oil 500 mg

ARTG number: 196604

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: S. cerevisiae Boulardii 5 Billion CFU Capsules

ARTG number: 193423

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Pages